| Identification | Back Directory | [Name]
2-Chloro-5,6,7,8-tetrahydro-pyrido[3,4-d]pyriMidine | [CAS]
1196153-06-6 | [Synonyms]
2-Chloro-5,6,7,8-tetrahydro-pyrido[3,4-d]pyriMidine | [Molecular Formula]
C7H8ClN3 | [MDL Number]
MFCD13189540 | [MOL File]
1196153-06-6.mol | [Molecular Weight]
169.612 |
| Chemical Properties | Back Directory | [Boiling point ]
356.8±32.0 °C(Predicted) | [density ]
1.297±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [pka]
6.80±0.20(Predicted) | [InChI]
InChI=1S/C7H8ClN3/c8-7-10-3-5-1-2-9-4-6(5)11-7/h3,9H,1-2,4H2 | [InChIKey]
YMJIKGJKYMEOCM-UHFFFAOYSA-N | [SMILES]
C1(Cl)=NC=C2CCNCC2=N1 |
| Questions and Answers (Q&A) | Back Directory | [Description]
2-Chloro-5, 6, 7, 8-tetrahydro-pyrido [3, 4-d] pyrimidine is a deriviative of pyrimidine. 5, 6, 7, 8-tetrahydropyrido[3, 4-d] pyrimidine compounds can act as mTOR kinase and PI3 kinase inhibitors and be used in the treatment of related metabolic diseases. It can also inhibit the extracellular signal-regulated kinase (Erks), and thus have potential to assist in the treatment of related tumor.
| [References]
https://www.mendeley.com/research-papers/5678tetrahydropyrido34dpyrimidine-compounds-mtor-kinase-pi3-kinase-inhibitors-preparation-treatment/
Blake, J. F., et al. "Discovery of 5, 6, 7, 8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2. " Bioorganic & Medicinal Chemistry Letters 24.12(2014):2635-2639.
|
|
|